Skip to content

Clinical trials

Phase 1 Glioblastoma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 1 Country / region: United Kingdom Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20091
20101
20112
20121
20151
20181
20222
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting2
Unknown status2
Active, not recruiting1
Terminated1
Withdrawn1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Cancer Research UK3
BerGenBio ASA1
Boehringer Ingelheim1
EMD Serono Research & Development Institute, Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
Hoffmann-La Roche1
Institute of Cancer Research, United Kingdom1
North Bristol NHS Trust1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma17
Brain Neoplasms5
Gliosarcoma5
Central Nervous System Neoplasms4
Neoplasms2
Astrocytoma1
Breast Neoplasms1
COVID-191
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.